Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +1.05% | 0.00% | +123.08% |
06-04 | LadRx Corporation and ImmunityBio, Inc. Mutually Agree to Terminate Aldoxorubicin License | CI |
05-15 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- LADX Stock
- Charts LadRx Corporation
- Total Return chart